Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 167,852 | 144,761 | 82,248 | 124,775 | 208,892 |
| Marketable Securities | N/A | N/A | N/A | 42,086 | 50,441 |
| Receivables | 140,190 | 80,142 | 48,494 | 33,729 | 22,934 |
| Inventories | 105,124 | 94,491 | 65,623 | 35,201 | 34,394 |
| Other current assets | 4,496 | 4,155 | 4,507 | 9,866 | 11,173 |
| TOTAL | $462,570 | $337,998 | $201,065 | $246,683 | $328,972 |
| Non-Current Assets | |||||
| PPE Net | 338 | 254 | 0 | 164 | 664 |
| Intangibles | 56 | 56 | 56 | 56 | 56 |
| Other Non-Current Assets | 2,922 | 5,513 | 4,675 | 1,036 | 51,898 |
| TOTAL | $3,316 | $5,823 | $4,731 | $1,256 | $52,618 |
| Total Assets | $465,886 | $343,821 | $205,796 | $247,939 | $381,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 65,068 | 51,650 | 31,718 | 23,040 | 17,559 |
| Accrued Expenses | 92,318 | 61,570 | 37,725 | 27,413 | 7,013 |
| Other current liabilities | 87,596 | 47,586 | 34,828 | 24,760 | 11,295 |
| TOTAL | $300,810 | $246,233 | $156,224 | $92,308 | $73,352 |
| Non-Current Liabilities | |||||
| Long Term Debt | 152,219 | 140,971 | 0 | N/A | N/A |
| Deferred Revenues | 34,477 | 8,518 | 25,402 | 3,507 | 5,683 |
| Other Non-Current Liabilities | 314,822 | 345,339 | 504,566 | 479,409 | 504,548 |
| TOTAL | $467,041 | $486,310 | $504,566 | $479,409 | $505,182 |
| Total Liabilities | $767,851 | $732,543 | $660,790 | $571,717 | $578,534 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 256,811 | 197,849 | 185,053 | 76,573 | 62,822 |
| Common Shares | 245 | 196 | 118 | 75 | 61 |
| Retained earnings | -1,623,711 | -1,601,029 | -1,549,284 | -1,340,036 | -1,106,377 |
| Other shareholders' equity | 2 | 2 | 2 | 0 | -29 |
| TOTAL | $-301,965 | $-388,722 | $-454,994 | $-323,778 | $-196,944 |
| Total Liabilities And Equity | $465,886 | $343,821 | $205,796 | $247,939 | $381,590 |